x
Filter:
Filters applied
- Reviews
- Andreone, PietroRemove Andreone, Pietro filter
Publication Date
Please choose a date range between 2011 and 2019.
Reviews
4 Results
- Review Article
Familial intrahepatic cholestasis: New and wide perspectives
Digestive and Liver DiseaseVol. 51Issue 7p922–933Published online: May 16, 2019- Giovanni Vitale
- Stefano Gitto
- Ranka Vukotic
- Francesco Raimondi
- Pietro Andreone
Cited in Scopus: 34Progressive familial intrahepatic cholestasis (PFIC) includes autosomal recessive cholestatic rare diseases of childhood. - Review ArticleOpen Access
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group
Digestive and Liver DiseaseVol. 51Issue 7p915–921Published online: April 25, 2019- Pietro Andreone
- Vito Di Marco
- Giovanni Battista Gaeta
- Stefano Fagiuoli
- Ranka Vukotic
- Antonio Craxì
Cited in Scopus: 11Hepatitis C virus (HCV) remains a significant public health problem and is one of the major causes of chronic liver disease worldwide. In recent years many new tools to facilitate widespread HCV screening and new therapeutic options with excellent efficacy and tolerability profiles and cost lowering policies have become available. To fully utilise these new tools, the link between local and specialist centres for the management of HCV infection must be reinforced. In order to GAIN further insight into these aspects, with a particular focus on the Italian scenario, a group of experts met to discuss relevant aspects and open issues on chronic HCV. - Review Article
Non-alcoholic steatohepatitis and liver transplantation
Digestive and Liver DiseaseVol. 48Issue 6p587–591Published online: March 31, 2016- Stefano Gitto
- Ranka Vukotic
- Giovanni Vitale
- Martina Pirillo
- Erica Villa
- Pietro Andreone
Cited in Scopus: 13Non-alcoholic steatohepatitis is a growing liver-related health problem. In Europe, non-alcoholic fatty liver disease is the most usual reason of chronic liver illness while steatohepatitis, its progressive form, affects 1% of Europeans and North Americans. In the United States steatohepatitis-related cirrhosis is one of the main indications for liver transplant. A targeted stratification for patients waiting for transplant and affected by this disease is mandatory especially because of their increased cardiovascular and cancer risk. - Review article
Liver transplantation for patients with alcoholic liver disease: An open question
Digestive and Liver DiseaseVol. 43Issue 11p843–849Published online: May 9, 2011- Annagiulia Gramenzi
- Stefano Gitto
- Fabio Caputo
- Maurizio Biselli
- Stefania Lorenzini
- Mauro Bernardi
- and others
Cited in Scopus: 19End-stage alcoholic liver disease is a recognised indication for liver transplantation but some questions on the matter remain open. It is difficult to quantify alcohol consumption, and a single definition of post-transplant relapse is lacking. Moreover, there are no internationally accepted criteria for the selection of candidates for liver transplantation and the eligibility parameters for these patients are controversial. Additional clinical and psychological evaluations are necessary in this setting, especially to establish the risk of alcohol relapse.